Pharmaceutical; Health Care; Biotech; Manufacturing; Consumer Products; Chemical; Media; Medical Device
Abbott Laboratories; Apria Healthcare; Abraxis; Laboratorios Deramtologicos Darier; Schering-Plough; Q-Med Scandinavia; Bausch & Lomb; Sciele Pharma; Allergan; Celgene; EMD Serono; AstraZeneca; Honeywell; Bayer Schering AG; IDS; Boehringer Ingelheim; King Pharmaceuticals; Eli Lilly and Company; Lundbeck; Genentech; Skila; Johnson & Johnson; Smith & Nephew; Merck; Ther-Rx; Novo Nordisk; Valeant; Pfizer; Roche; Sanofi-Aventis
Research was conducted through survey and interviews of thirty-two participants, sixteen of whom were large research-based Pharmaceutical companies of the world.
Key study objectives include:
- Identifying common practices in measuring Managed Markets account executive performance.
- Gaining insight into the principles of effective measurement of this function.
- Determining what specific measures are used to drive successful activity in Managed Markets account management.